28.02.2013 Views

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

autologous blood and marrow transplantation - Blog Science ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

24 Chapter 1: AML<br />

exhibit low-density CD45 expression <strong>and</strong> low side-scatter characteristics, a series<br />

of four gates were used to generate events considered to be true progenitor/stem<br />

cells. Cells within the final progenitor/stem cell gate can be distinguished from<br />

lymphocytes, monocytes, granulocytes, <strong>and</strong> other events that can contaminate the<br />

CD34 +<br />

population.<br />

Preparative regimens<br />

Thirty-five patients were treated with the following preparative regimen: Cy (60<br />

mg/kg intravenously for 2 days, days -5 to -3) <strong>and</strong> fractionated total body<br />

irradiation (TBI) (200 cGy twice daily for 3 days, total dose of 1200 cGy, dose rate<br />

5 to 10 cGy/min, days -2 to 0). In 1988, the preparative regimen was changed<br />

from Cy/TBI to busulfan (BU)/Cy2. Ninety-three patients were treated with BU (4<br />

mg/kg/d orally for days -8 to -5) <strong>and</strong> Cy (60 mg/kg/d intravenously for 2 days,<br />

days -4 <strong>and</strong> -3). One patient in CR2 was treated with BU (4 mg/kg/d orally for<br />

4 days, days -9 to -6) <strong>and</strong> Cy (50 mg/kg/d intravenously for 4 days, days -5 to<br />

-2). Ten patients (Stanford) were conditioned with BU (4 mg/kg/d orally, days -7<br />

to -4) <strong>and</strong> VP-16 (60 mg/kg, day -3).<br />

Statistical methods<br />

Two patient sets were included in this analysis: the first was the total set of 138<br />

patients <strong>and</strong> the second was the set of 55 patients who underwent autoBMT in<br />

CR2/3 <strong>and</strong> received BU/Cy as their conditioning regimen. For both analyses, the<br />

last transplant represented was performed on 10 February 1997 <strong>and</strong> the last followup<br />

contact was 25 September 1997.<br />

We estimated rates of relapse, overall survival (OS), <strong>and</strong> disease-free survival<br />

after autoBMT (<strong>and</strong> 95% confidence intervals [CIs]) using the product-limit or<br />

Kaplan-Meier method. 27<br />

In addition, proportional hazards regression (Cox regression, relative risk<br />

regression) was used to investigate the association of factors of interest with OS<br />

<strong>and</strong> DFS in these patients. 28<br />

The factors listed in Table 2 were allowed to enter the<br />

05 <strong>and</strong> DFS models in a forward stepwise fashion (i.e., factors were evaluated first<br />

individually to see whether they contributed substantially to predicting outcome).<br />

The most significant univariate factor was then forced into the model, other factors<br />

being allowed to enter if they contributed significantly given the presence of the<br />

first. Additional factors were allowed to enter the models with interactions as<br />

appropriate.<br />

Some factors were transformed before analysis using logarithms to make their<br />

distributions more symmetric. Body mass index was calculated as weight<br />

(kg)/height (m) 2<br />

.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!